Efficacy, Safety and Tolerability of Nangibotide in Patients With Septic Shock
Efficacy, Safety and Tolerability of Nangibotide in Patients With Septic Shock
Active, not recruiting · NCT04055909 · Registry updated 2023-04-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy, Safety and Tolerability of Nangibotide in Patients With Septic Shock | Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Shock, Systemic Inflammatory Response Syndrome, toxic shock syndrome | Active, not recruiting | Phase 2 | 2023-04-11 | NCT04055909 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Inotrem | 2 |
43 results · Page 1 of 2
Research sites
Swipe the table sideways for more columns.